Keryx

Gee, thanks for your insightful and ingenious thoughts and post. Aren't you a modern day Dick Tracey.

 

After reading this and talking to some peers who took positions here, I am glad I didn't follow up with recruiter. At the time I was just so busy traveling that I never called her back.

 

and you're just a dick.

 

Yes I am. Come suck me.

 

How many calls do you need to make per day?

 

How bad is it?

 

If situation is so bad why is the stock still so high? I know this stuff is hard to sell but smart boys traders seem to think differently. What do they know that reps who are in the field selling don't know?

 

What is your definition of high? Do a search of the stock performance for 1 year and you will see it is not "high". In addition if you had any business/market sense you would understand that the whole biotech/pharma indexes are running at historical highs therefore all companies in this sector benefit from potentially inflated valuations/stock prices. Your post reeks of an true stock market and healthcare amateur trying to provide insights on a topic in which they are clueless.

 

My apologies for having the expectation that there would be some underlying value to a business other than the casino where the cash comes from the printing machine that is fueling the biotech bubble. If one goes by the bigger fool business model you are correct and I stand corrected- this stock is not "high" all you have to do is look for a bigger fool.

 

Beware shareholders, hope they are not counting their free vouchers as actual paid for RX, Galina did this and look what it did to their stock when they were called out for doing so, the ticker is GALE.

 

Look for the analysts to question refill rates vs NRx vs TRx trends. They will not match since many of the TRxs generated look fairly decent since they are using the free vouchers but the refill rate is very low. This tells a very compelling story about the true success of the product in the market. This does not look good.

 

Updates???

 

nice BLACK BOX WARNING

 

GM announced as the new CEO and stock dives over 5%. Run!

 

You thing the failure of this stock any anything to do with the CEO? Look at the sales results. Look at your sales leadership (VP Sales). Look at the free product you consistently give away in the hope of getting a refill. Look at the markket share you have in the FMS clinics. Look at your middle mgt Team. Look at the clinical profile of your drug, its a me too. You have a solution trying to create a problem in an environment cost cutting and simplicity. This place is a complete failure to date and the performance of the stock pre-launch through post launch is the most accurate way to measure the success.

 

Look at the stock price now. Down below $8 yesterday. Scripts are not being refilled and sample bottles are 30 days. This product will not take off unless they get a pre-dialysis indication

 

Dear Sales Force:

You are fucked!

Sincerely,
The Competition

 

Dont work here but who had the bright idea to give 30 day sample bottles out? Kiss of death in a launch or near launch mode. Pharma launch 101.

 

Roth capital downgrades KERX, sets 53 week price target to $6. The stock is below $6 now with key technical indicators showing stock can go below $5 per share by mid Sept. It seems like the board may have to make a decision on the direction of this companies leadership, glad I sold my shares long ago. Too bad for those who were offered stock options and are underwater, options are fools gold in many cases anyway and this is the proof.